Which has the lower trailing P/E, NA or UHS?

NA has the lower trailing P/E: NA trades at 2.30 and UHS at 6.69. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, NA or UHS?

Over the past five years, NA grew revenue faster — NA at a 64.16% CAGR versus UHS at 8.63%.

Does NA or UHS pay a bigger dividend?

UHS pays a dividend (0.50% yield), while NA has no payments in the available dividend history.

Is NA or UHS more profitable?

NA runs the higher net margin — NA at 505.49% versus UHS at 8.56%.

Nano Labs Ltd (NA) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of Nano Labs Ltd and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: NA is classified in Technology; UHS is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

Nano Labs Ltd

$119M

$1.76TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT

UHS

Universal Health Services, Inc.

$10.06B

$166.22HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — NA vs UHS

growth of $100 · dividends reinvested · last 4y

NA -98.4%UHS +61.4%UHS compounded faster

Log scale — wide-divergence pair

NA UHS

NA vs UHS: by the numbers

•UHS is the larger company ($10.06B vs $119M market cap).
•NA trades at the lower trailing earnings multiple (2.30 vs 6.69 P/E), one valuation lens rather than an overall verdict.
•NA converts more revenue to profit (505.49% vs 8.56% net margin).
•NA grew revenue faster over the past five years (64.16% vs 8.63% CAGR).
•UHS pays a dividend (0.50% yield), while NA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	NA	UHS
P/E ratio	2.30	6.69
Forward P/E	N/A	6.79
P/S ratio	11.40	0.55
P/B ratio	0.41	1.31
PEG ratio	N/A	0.26
EV / EBITDA	6.44	5.56
FCF yield	N/A	9.09%

Profitability

Metric	NA	UHS
Gross margin	-147.33%	90.45%
Operating margin	-396.84%	11.50%
Net margin	505.49%	8.56%
ROE	17.96%	20.19%
ROIC	-10.96%	11.29%

Dividends

Metric	NA	UHS
Dividend yield	N/A	0.50%
Payout ratio	N/A	3.42%

Growth (annualized)

Metric	NA	UHS
Revenue CAGR (5Y)	64.16%	8.63%
EPS CAGR (5Y)	N/A	16.19%
FCF CAGR (5Y)	N/A	-4.64%
Total return CAGR (5Y)	N/A	0.55%

Frequently asked

Which has the lower trailing P/E, NA or UHS?: NA has the lower trailing P/E: NA trades at 2.30 and UHS at 6.69. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, NA or UHS?: Over the past five years, NA grew revenue faster — NA at a 64.16% CAGR versus UHS at 8.63%.
Does NA or UHS pay a bigger dividend?: UHS pays a dividend (0.50% yield), while NA has no payments in the available dividend history.
Is NA or UHS more profitable?: NA runs the higher net margin — NA at 505.49% versus UHS at 8.56%.

Go deeper

Full NA analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

Nano Labs P/E ratio Universal Health Services P/E ratio Nano Labs dividend yield Universal Health Services dividend yield Nano Labs ROE Universal Health Services ROE Nano Labs operating margin Universal Health Services operating margin Nano Labs revenue growth Universal Health Services revenue growth Nano Labs free cash flow Universal Health Services free cash flow

Nano Labs & Universal Health Services appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.